It was my turn to present an article at the Clinical Pharmacology Journal Club yesterday. This was something I took very seriously and I spent hours analysing my chosen article and working on my Powerpoint presentation. I also prepared a batch of delicious biscuits to bribe my audience into listening attentively.
In hindsight, I probably shouldn't have chosen a review article about a drug that was written by someone on the payroll of the drug company. And I could have found a more reputable journal than "Swiss Medical Weekly" which, I think, is only published online. But it gave me plenty to talk about, I learned a little about dronedarone (an amiodarone derivative that is less effective but less toxic - unless you count the liver damage), and now everybody has heard of a journal called Swiss Medical Weekly.
So we all learned something.